Markus W. Büchler

Active 1985–2025

569
Papers
106,028
Citations
172
h-index
551
i10-index

Citations

Citations per year for Markus W. Büchler1939: 1 citations1975: 1 citations1978: 1 citations1985: 1 citations1986: 3 citations1987: 14 citations1988: 17 citations1989: 30 citations1990: 22 citations1991: 27 citations1992: 22 citations1993: 46 citations1994: 51 citations1995: 77 citations1996: 65 citations1997: 152 citations1998: 199 citations1999: 267 citations2000: 277 citations2001: 324 citations2002: 366 citations2003: 403 citations2004: 334 citations2005: 432 citations2006: 482 citations2007: 536 citations2008: 594 citations2009: 525 citations2010: 597 citations2011: 616 citations2012: 695 citations2013: 837 citations2014: 810 citations2015: 787 citations2016: 885 citations2017: 830 citations2018: 778 citations2019: 3,065 citations2020: 3,240 citations2021: 2,918 citations2022: 1,933 citations2023: 1,460 citations2024: 2,440 citations2025: 992 citations2026: 18 citations1940–1974: no citations, so these years are not shown1976–1977: no citations, so these years are not shown1979–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,162 citing papers, 20.9% of this breakdownChina: 3,363 citing papers, 11.4% of this breakdownGermany: 2,515 citing papers, 8.6% of this breakdownItaly: 1,872 citing papers, 6.4% of this breakdownUnited Kingdom: 1,747 citing papers, 5.9% of this breakdownJapan: 1,560 citing papers, 5.3% of this breakdownNetherlands: 1,166 citing papers, 4% of this breakdownFrance: 1,087 citing papers, 3.7% of this breakdownCanada: 756 citing papers, 2.6% of this breakdownSpain: 748 citing papers, 2.5% of this breakdownSouth Korea: 653 citing papers, 2.2% of this breakdownAustralia: 628 citing papers, 2.1% of this breakdown
0%20.9%Other 24.4%

Fields

  • Medicine71.7%
  • Biochemistry, Genetics and Molecular Biology20.3%
  • Immunology and Microbiology3.1%
  • Neuroscience1.4%
  • Engineering0.9%
  • Computer Science0.5%
  • Other2.1%

Topics

  • Pancreatic and Hepatic Oncology Research11.3%
  • Pancreatitis Pathology and Treatment5.5%
  • Gallbladder and Bile Duct Disorders2.9%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.9%
  • Cancer Cells and Metastasis2%
  • Colorectal Cancer Surgical Treatments1.7%
  • Other73.7%

Coauthors

All papers

Open in search
  1. Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)

    Authors: , , , , , , , , , , , - Surgery 2007 cited by 2,993

  2. Postpancreatectomy hemorrhage (PPH)–An International Study Group of Pancreatic Surgery (ISGPS) definition

    Authors: , , , , , , , , , , , - Surgery 2007 cited by 2,569

  3. Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Surgery 2011 cited by 2,273

  4. Neoadjuvant therapy for pancreatic cancer

    Authors: , , , , , , , - Nature Reviews Clinical Oncology 2023 cited by 358

  5. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pascal Hammel, Thilo Hackert, Richard Jackson, Markus W. Büchler - The Lancet 2017 cited by 1,928

  6. Optimizing the outcomes of pancreatic cancer surgery

    Authors: , , , - Nature Reviews Clinical Oncology 2018 cited by 965

  7. Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Surgery 2011 cited by 1,937

  8. Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer

    Authors: , , , , , , , , , , , , , - Surgery 2009 cited by 1,529

  9. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christoph Springfeld, Christine Tjaden, Thilo Hackert, Markus W. Büchler, John P. Neoptolemos - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 325

  10. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system

    Authors: , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2022 cited by 146

  11. A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2004 cited by 2,708

  12. Spatially Resolved Multi-Omics Single-Cell Analyses Inform Mechanisms of Immune Dysfunction in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2023 cited by 100

  13. Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2010 cited by 1,387

  14. Combined evaluation of a panel of protein and miRNA serum‐exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity

    Authors: , , , , , , , , , , - International Journal of Cancer 2014 cited by 494

  15. Colorectal cancer

    Authors: , , , , , - The Lancet 2005 cited by 1,109

  16. Pancreatic Neuropathy and Neuropathic Pain—A Comprehensive Pathomorphological Study of 546 Cases

    Authors: , , , , , , , , , , - Gastroenterology 2008 cited by 415

  17. Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Surgery 2014 cited by 948

  18. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - HPB 2011 cited by 452

  19. Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Surgery 2016 cited by 390

  20. Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Borg, Sharmila Sothi, Pascal Hammel, Markus M. Lerch, Julia Mayerle, Christine Tjaden, Oliver Strobel, Thilo Hackert, Markus W. Büchler, John P. Neoptolemos, for the European Study Group for Pancreatic Cancer - JAMA Surgery 2019 cited by 273

  21. Optimal literature search for systematic reviews in surgery

    Authors: , , , , , , - Langenbeck s Archives of Surgery 2017 cited by 251

  22. Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2023 cited by 57

  23. Locally Advanced Pancreatic Cancer

    Authors: , , , , , , , , , - Annals of Surgery 2016 cited by 534

  24. Chemotherapy for pancreatic cancer

    Authors: , , , , , , - La Presse Médicale 2019 cited by 289